-+ 0.00%
-+ 0.00%
-+ 0.00%

Keybanc Maintains Overweight on Progyny, Raises Price Target to $35

Benzinga·07/13/2026 12:25:47
Listen to the news
Keybanc analyst Scott Schoenhaus maintains Progyny (NASDAQ:PGNY) with a Overweight and raises the price target from $30 to $35.